The global Interferon Alpha-2a Biosimilar revenue was US$ 211 million in 2022 and is forecast to a readjusted size of US$ 92 million by 2029 with a CAGR of -11.0% during the forecast period (2023-2029).

and India Interferon Alpha-2a Biosimilar Market

Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences.

In India, the Interferon Alpha-2a Biosimilar revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).

Global Interferon Alpha-2a Biosimilar key players include Roche, Biosidus, Zydus Cadila, Nanogen, Amega Biotech, etc. Global top five manufacturers hold a share about 95%. Europe is the largest market, with a share about 60%, followed by Asia, with a share about 10 percent. In terms of product, Ordinary Type is the largest segment, with a share about 70%. And in terms of application, the largest application is Hepatitis C, followed by Hepatitis B, etc.

This report focuses on global and India Interferon Alpha-2a Biosimilar market, also covers the segmentation data of other regions in regional level and county level.

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for Interferon Alpha-2a Biosimilar will continue to grow rapidly in the future.

Global Interferon Alpha-2a Biosimilar Scope and Market Size

Interferon Alpha-2a Biosimilar market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Interferon Alpha-2a Biosimilar market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.

For India market, this report focuses on the Interferon Alpha-2a Biosimilar market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Interferon Alpha-2a Biosimilar Market Report

Report Metric	Details
Report Name	and India Interferon Alpha-2a Biosimilar Market
Forecasted market size in 2029	US$ 92 million
Forecasted years	2023 - 2029
Segment by Type	Long-lasting Type Ordinary Type
Segment by Application	Hepatitis C Hepatitis B Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Biosidus, Zydus Cadila, Nanogen, Amega Biotech, Rhein Minapharm Biogenetics, PROBIOMED, 3sbio
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Interferon Alpha-2a Biosimilar Market size in 2029?

Ans: The and India Interferon Alpha-2a Biosimilar Market size in 2029 will be US$ 92 million.

What is the market share of major companies in and India Interferon Alpha-2a Biosimilar Market?

Ans: Global top five manufacturers hold a share about 95%.

What is the and India Interferon Alpha-2a Biosimilar Market share by type?

Ans: In terms of product, Ordinary Type is the largest segment, with a share about 70%.

What is the and India Interferon Alpha-2a Biosimilar Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Interferon Alpha-2a Biosimilar Market report?

Ans: The main players in the and India Interferon Alpha-2a Biosimilar Market are Roche, Biosidus, Zydus Cadila, Nanogen, Amega Biotech, Rhein Minapharm Biogenetics, PROBIOMED, 3sbio

What are the Application segmentation covered in the and India Interferon Alpha-2a Biosimilar Market report?

Ans: The Applications covered in the and India Interferon Alpha-2a Biosimilar Market report are Hepatitis C, Hepatitis B, Others

What are the Type segmentation covered in the and India Interferon Alpha-2a Biosimilar Market report?

Ans: The Types covered in the and India Interferon Alpha-2a Biosimilar Market report are Long-lasting Type, Ordinary Type

1 Study Coverage

1.1 Interferon Alpha-2a Biosimilar Product Introduction

1.2 Global Interferon Alpha-2a Biosimilar Outlook 2018 VS 2022 VS 2029

1.2.1 Global Interferon Alpha-2a Biosimilar Sales in US$ Million for the Year 2018-2029

1.2.2 Global Interferon Alpha-2a Biosimilar Sales in Volume for the Year 2018-2029

1.3 India Interferon Alpha-2a Biosimilar Outlook 2018 VS 2022 VS 2029

1.3.1 India Interferon Alpha-2a Biosimilar Sales in US$ Million for the Year 2018-2029

1.3.2 India Interferon Alpha-2a Biosimilar Sales in Volume for the Year 2018-2029

1.4 Interferon Alpha-2a Biosimilar Market Size, India VS Global, 2018 VS 2022 VS 2029

1.4.1 The Market Share of India Interferon Alpha-2a Biosimilar in Global, 2018 VS 2022 VS 2029

1.4.2 The Growth Rate of Interferon Alpha-2a Biosimilar Market Size, India VS Global, 2018 VS 2022 VS 2029

1.5 Interferon Alpha-2a Biosimilar Market Dynamics

1.5.1 Interferon Alpha-2a Biosimilar Industry Trends

1.5.2 Interferon Alpha-2a Biosimilar Market Drivers

1.5.3 Interferon Alpha-2a Biosimilar Market Challenges

1.5.4 Interferon Alpha-2a Biosimilar Market Restraints

1.6 Study Objectives

1.7 Years Considered

1.8 Years Considered

2 Interferon Alpha-2a Biosimilar by Type

2.1 Interferon Alpha-2a Biosimilar Market Segment by Type

2.1.1 Long-lasting Type

2.1.2 Ordinary Type

2.2 Global Interferon Alpha-2a Biosimilar Market Size by Type

2.2.1 Global Interferon Alpha-2a Biosimilar Sales in Value, by Type (2018, 2022 & 2029)

2.2.2 Global Interferon Alpha-2a Biosimilar Sales in Volume, by Type (2018, 2022 & 2029)

2.2.3 Global Interferon Alpha-2a Biosimilar Average Selling Price (ASP) by Type (2018, 2022 & 2029)

2.3 India Interferon Alpha-2a Biosimilar Market Size by Type

2.3.1 India Interferon Alpha-2a Biosimilar Sales in Value, by Type (2018, 2022 & 2029)

2.3.2 India Interferon Alpha-2a Biosimilar Sales in Volume, by Type (2018, 2022 & 2029)

2.3.3 India Interferon Alpha-2a Biosimilar Average Selling Price (ASP) by Type (2018, 2022 & 2029)

3 Interferon Alpha-2a Biosimilar by Application

3.1 Interferon Alpha-2a Biosimilar Market Segment by Application

3.1.1 Hepatitis C

3.1.2 Hepatitis B

3.1.3 Others

3.2 Global Interferon Alpha-2a Biosimilar Market Size by Application

3.2.1 Global Interferon Alpha-2a Biosimilar Sales in Value, by Application (2018, 2022 & 2029)

3.2.2 Global Interferon Alpha-2a Biosimilar Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 Global Interferon Alpha-2a Biosimilar Average Selling Price (ASP) by Application (2018, 2022 & 2029)

3.3 India Interferon Alpha-2a Biosimilar Market Size by Application

3.3.1 India Interferon Alpha-2a Biosimilar Sales in Value, by Application (2018, 2022 & 2029)

3.3.2 India Interferon Alpha-2a Biosimilar Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 India Interferon Alpha-2a Biosimilar Average Selling Price (ASP) by Application (2018, 2022 & 2029)

4 Global Interferon Alpha-2a Biosimilar Competitor Landscape by Company

4.1 Global Interferon Alpha-2a Biosimilar Market Size by Company

4.1.1 Global Key Manufacturers of Interferon Alpha-2a Biosimilar, Ranked by Revenue (2022)

4.1.2 Global Interferon Alpha-2a Biosimilar Revenue by Manufacturer (2018-2023)

4.1.3 Global Interferon Alpha-2a Biosimilar Sales by Manufacturer (2018-2023)

4.1.4 Global Interferon Alpha-2a Biosimilar Price by Manufacturer (2018-2023)

4.2 Global Interferon Alpha-2a Biosimilar Concentration Ratio (CR)

4.2.1 Interferon Alpha-2a Biosimilar Market Concentration Ratio (CR)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Interferon Alpha-2a Biosimilar in 2022

4.2.3 Global Interferon Alpha-2a Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Manufacturers of Interferon Alpha-2a Biosimilar, Manufacturing Base Distribution and Headquarters

4.4 Global Key Manufacturers of Interferon Alpha-2a Biosimilar, Product Offered and Application

4.5 Global Key Manufacturers of Interferon Alpha-2a Biosimilar, Date of Enter into This Industry

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.7 India Interferon Alpha-2a Biosimilar Market Size by Company

4.7.1 Key Players of Interferon Alpha-2a Biosimilar in India, Ranked by Revenue (2022)

4.7.2 India Interferon Alpha-2a Biosimilar Revenue by Players (2018-2023)

4.7.3 India Interferon Alpha-2a Biosimilar Sales by Players (2018-2023)

5 Global Interferon Alpha-2a Biosimilar Market Size by Region

5.1 Global Interferon Alpha-2a Biosimilar Market Size by Region: 2018 VS 2022 VS 2029

5.2 Global Interferon Alpha-2a Biosimilar Market Size in Volume by Region (2018-2029)

5.2.1 Global Interferon Alpha-2a Biosimilar Sales in Volume by Region: 2018-2023

5.2.2 Global Interferon Alpha-2a Biosimilar Sales in Volume Forecast by Region (2024-2029)

5.3 Global Interferon Alpha-2a Biosimilar Market Size in Value by Region (2018-2029)

5.3.1 Global Interferon Alpha-2a Biosimilar Sales in Value by Region: 2018-2023

5.3.2 Global Interferon Alpha-2a Biosimilar Sales in Value by Region: 2024-2029

6 Americas

6.1 Americas Interferon Alpha-2a Biosimilar Market Size YoY Growth 2018-2029

6.2 Americas Interferon Alpha-2a Biosimilar Sales in Volume, by Type (2018, 2022 & 2029)

6.3 Americas Interferon Alpha-2a Biosimilar Sales in Volume, by Application (2018, 2022 & 2029)

6.4 Americas Interferon Alpha-2a Biosimilar Market Facts & Figures by Country (2018, 2022 & 2029)

6.4.1 Americas Interferon Alpha-2a Biosimilar Sales in Value by Country (2018, 2022 & 2029)

6.4.2 Americas Interferon Alpha-2a Biosimilar Sales in Volume by Country (2018, 2022 & 2029)

6.4.3 United States

6.4.4 Canada

6.4.5 Mexico

6.4.6 Brazil

7 EMEA

7.1 EMEA Interferon Alpha-2a Biosimilar Market Size YoY Growth 2018-2029

7.2 EMEA Interferon Alpha-2a Biosimilar Sales in Volume, by Type (2018, 2022 & 2029)

7.3 EMEA Interferon Alpha-2a Biosimilar Sales in Volume, by Application (2018, 2022 & 2029)

7.4 EMEA Interferon Alpha-2a Biosimilar Market Facts & Figures by Country (2018, 2022 & 2029)

7.4.1 EMEA Interferon Alpha-2a Biosimilar Sales in Value by Country (2018, 2022 & 2029)

7.4.2 EMEA Interferon Alpha-2a Biosimilar Sales in Volume by Country (2018, 2022 & 2029)

7.4.3 Europe

7.4.4 Middle East

7.4.5 Africa

8 China

8.1 China Interferon Alpha-2a Biosimilar Market Size YoY Growth 2018-2029

8.2 China Interferon Alpha-2a Biosimilar Sales in Volume, by Type (2018, 2022 & 2029)

8.3 China Interferon Alpha-2a Biosimilar Sales in Volume, by Application (2018, 2022 & 2029)

9 APAC

9.1 APAC Interferon Alpha-2a Biosimilar Market Size YoY Growth 2018-2029

9.2 APAC Interferon Alpha-2a Biosimilar Sales in Volume, by Type (2018, 2022 & 2029)

9.3 APAC Interferon Alpha-2a Biosimilar Sales in Volume, by Application (2018, 2022 & 2029)

9.4 APAC Interferon Alpha-2a Biosimilar Market Facts & Figures by Region (2018, 2022 & 2029)

9.4.1 APAC Interferon Alpha-2a Biosimilar Sales in Value by Region (2018, 2022 & 2029)

9.4.2 APAC Interferon Alpha-2a Biosimilar Sales in Volume by Region (2018, 2022 & 2029)

9.4.3 Japan

9.4.4 South Korea

9.4.5 China Taiwan

9.4.6 Southeast Asia

9.4.7 India

10 Company Profiles

10.1 Roche

10.1.1 Roche Company Information

10.1.2 Roche Description and Business Overview

10.1.3 Roche Interferon Alpha-2a Biosimilar Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Roche Interferon Alpha-2a Biosimilar Products Offered

10.1.5 Roche Recent Development

10.2 Biosidus

10.2.1 Biosidus Company Information

10.2.2 Biosidus Description and Business Overview

10.2.3 Biosidus Interferon Alpha-2a Biosimilar Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Biosidus Interferon Alpha-2a Biosimilar Products Offered

10.2.5 Biosidus Recent Development

10.3 Zydus Cadila

10.3.1 Zydus Cadila Company Information

10.3.2 Zydus Cadila Description and Business Overview

10.3.3 Zydus Cadila Interferon Alpha-2a Biosimilar Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Zydus Cadila Interferon Alpha-2a Biosimilar Products Offered

10.3.5 Zydus Cadila Recent Development

10.4 Nanogen

10.4.1 Nanogen Company Information

10.4.2 Nanogen Description and Business Overview

10.4.3 Nanogen Interferon Alpha-2a Biosimilar Sales, Revenue and Gross Margin (2018-2023)

10.4.4 Nanogen Interferon Alpha-2a Biosimilar Products Offered

10.4.5 Nanogen Recent Development

10.5 Amega Biotech

10.5.1 Amega Biotech Company Information

10.5.2 Amega Biotech Description and Business Overview

10.5.3 Amega Biotech Interferon Alpha-2a Biosimilar Sales, Revenue and Gross Margin (2018-2023)

10.5.4 Amega Biotech Interferon Alpha-2a Biosimilar Products Offered

10.5.5 Amega Biotech Recent Development

10.6 Rhein Minapharm Biogenetics

10.6.1 Rhein Minapharm Biogenetics Company Information

10.6.2 Rhein Minapharm Biogenetics Description and Business Overview

10.6.3 Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Sales, Revenue and Gross Margin (2018-2023)

10.6.4 Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Products Offered

10.6.5 Rhein Minapharm Biogenetics Recent Development

10.7 PROBIOMED

10.7.1 PROBIOMED Company Information

10.7.2 PROBIOMED Description and Business Overview

10.7.3 PROBIOMED Interferon Alpha-2a Biosimilar Sales, Revenue and Gross Margin (2018-2023)

10.7.4 PROBIOMED Interferon Alpha-2a Biosimilar Products Offered

10.7.5 PROBIOMED Recent Development

10.8 3sbio

10.8.1 3sbio Company Information

10.8.2 3sbio Description and Business Overview

10.8.3 3sbio Interferon Alpha-2a Biosimilar Sales, Revenue and Gross Margin (2018-2023)

10.8.4 3sbio Interferon Alpha-2a Biosimilar Products Offered

10.8.5 3sbio Recent Development

11 Industry Chain and Sales Channels Analysis

11.1 Interferon Alpha-2a Biosimilar Industry Chain Analysis

11.2 Interferon Alpha-2a Biosimilar Key Raw Materials

11.2.1 Key Raw Materials

11.2.2 Raw Materials Key Suppliers

11.3 Interferon Alpha-2a Biosimilar Production Mode & Process

11.4 Interferon Alpha-2a Biosimilar Sales and Marketing

11.4.1 Interferon Alpha-2a Biosimilar Sales Channels

11.4.2 Interferon Alpha-2a Biosimilar Distributors

11.5 Interferon Alpha-2a Biosimilar Customers

12 Research Findings and Conclusion

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Rhein Minapharm Biogenetics

PROBIOMED

3SBio Inc

List of Tables

Table 1. Interferon Alpha-2a Biosimilar CAGR in Value, India VS Global, 2018 VS 2022 VS 2029

Table 2. Interferon Alpha-2a Biosimilar Market Trends

Table 3. Interferon Alpha-2a Biosimilar Market Drivers

Table 4. Interferon Alpha-2a Biosimilar Market Challenges

Table 5. Interferon Alpha-2a Biosimilar Market Restraints

Table 6. Global Interferon Alpha-2a Biosimilar Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 7. India Interferon Alpha-2a Biosimilar Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 8. Global Interferon Alpha-2a Biosimilar Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 9. India Interferon Alpha-2a Biosimilar Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 10. Global Key Manufacturers of Interferon Alpha-2a Biosimilar, Ranked by Revenue (2022) & (US$ Million)

Table 11. Global Interferon Alpha-2a Biosimilar Revenue by Manufacturer, (US$ Million), 2018-2023

Table 12. Global Interferon Alpha-2a Biosimilar Revenue Share by Manufacturer, 2018-2023

Table 13. Global Interferon Alpha-2a Biosimilar Sales by Manufacturer, (K Units), 2018-2023

Table 14. Global Interferon Alpha-2a Biosimilar Sales Share by Manufacturer, 2018-2023

Table 15. Global Interferon Alpha-2a Biosimilar Price by Manufacturer (2018-2023) & (USD/Unit)

Table 16. Global Interferon Alpha-2a Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global Interferon Alpha-2a Biosimilar by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interferon Alpha-2a Biosimilar as of 2022)

Table 18. Global Key Manufacturers of Interferon Alpha-2a Biosimilar, Manufacturing Base Distribution and Headquarters

Table 19. Global Key Manufacturers of Interferon Alpha-2a Biosimilar, Product Offered and Application

Table 20. Global Key Manufacturers of Interferon Alpha-2a Biosimilar, Date of Enter into This Industry

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Key Players of Interferon Alpha-2a Biosimilar in India, Ranked by Revenue (2022) & (US$ million)

Table 23. India Interferon Alpha-2a Biosimilar Revenue by Players, (US$ Million), (2018-2023)

Table 24. India Interferon Alpha-2a Biosimilar Revenue Share by Players, (2018-2023)

Table 25. India Interferon Alpha-2a Biosimilar Sales by Players, (K Units), (2018-2023)

Table 26. India Interferon Alpha-2a Biosimilar Sales Share by Players, (2018-2023)

Table 27. Global Interferon Alpha-2a Biosimilar Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 28. Global Interferon Alpha-2a Biosimilar Sales in Volume by Region (2018-2023) & (K Units)

Table 29. Global Interferon Alpha-2a Biosimilar Sales in Volume Forecast by Region (2024-2029) & (K Units)

Table 30. Global Interferon Alpha-2a Biosimilar Sales in Value by Region (2018-2023) & (US$ Million)

Table 31. Global Interferon Alpha-2a Biosimilar Sales in Value Forecast by Region (2024-2029) & (US$ Million)

Table 32. Americas Interferon Alpha-2a Biosimilar Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 33. Americas Interferon Alpha-2a Biosimilar Sales in Value by Country (2018-2023) & (US$ Million)

Table 34. Americas Interferon Alpha-2a Biosimilar Sales in Value by Country (2024-2029) & (US$ Million)

Table 35. Americas Interferon Alpha-2a Biosimilar Sales in Volume by Country (2018-2023) & (K Units)

Table 36. Americas Interferon Alpha-2a Biosimilar Sales in Volume by Country (2024-2029) & (K Units)

Table 37. EMEA Interferon Alpha-2a Biosimilar Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 38. EMEA Interferon Alpha-2a Biosimilar Sales in Value by Country (2018-2023) & (US$ Million)

Table 39. EMEA Interferon Alpha-2a Biosimilar Sales in Value by Country (2024-2029) & (US$ Million)

Table 40. EMEA Interferon Alpha-2a Biosimilar Sales in Volume by Country (2018-2023) & (K Units)

Table 41. EMEA Interferon Alpha-2a Biosimilar Sales in Volume by Country (2024-2029) & (K Units)

Table 42. APAC Interferon Alpha-2a Biosimilar Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. APAC Interferon Alpha-2a Biosimilar Sales in Value by Country (2018-2023) & (US$ Million)

Table 44. APAC Interferon Alpha-2a Biosimilar Sales in Value by Country (2024-2029) & (US$ Million)

Table 45. APAC Interferon Alpha-2a Biosimilar Sales in Volume by Country (2018-2023) & (K Units)

Table 46. APAC Interferon Alpha-2a Biosimilar Sales in Volume by Country (2024-2029) & (K Units)

Table 47. Roche Company Information

Table 48. Roche Description and Business Overview

Table 49. Roche Interferon Alpha-2a Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 50. Roche Interferon Alpha-2a Biosimilar Product

Table 51. Roche Recent Development

Table 52. Biosidus Company Information

Table 53. Biosidus Description and Business Overview

Table 54. Biosidus Interferon Alpha-2a Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 55. Biosidus Interferon Alpha-2a Biosimilar Product

Table 56. Biosidus Recent Development

Table 57. Zydus Cadila Company Information

Table 58. Zydus Cadila Description and Business Overview

Table 59. Zydus Cadila Interferon Alpha-2a Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 60. Zydus Cadila Interferon Alpha-2a Biosimilar Product

Table 61. Zydus Cadila Recent Development

Table 62. Nanogen Company Information

Table 63. Nanogen Description and Business Overview

Table 64. Nanogen Interferon Alpha-2a Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 65. Nanogen Interferon Alpha-2a Biosimilar Product

Table 66. Nanogen Recent Development

Table 67. Amega Biotech Company Information

Table 68. Amega Biotech Description and Business Overview

Table 69. Amega Biotech Interferon Alpha-2a Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 70. Amega Biotech Interferon Alpha-2a Biosimilar Product

Table 71. Amega Biotech Recent Development

Table 72. Rhein Minapharm Biogenetics Company Information

Table 73. Rhein Minapharm Biogenetics Description and Business Overview

Table 74. Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 75. Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Product

Table 76. Rhein Minapharm Biogenetics Recent Development

Table 77. PROBIOMED Company Information

Table 78. PROBIOMED Description and Business Overview

Table 79. PROBIOMED Interferon Alpha-2a Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 80. PROBIOMED Interferon Alpha-2a Biosimilar Product

Table 81. PROBIOMED Recent Development

Table 82. 3sbio Company Information

Table 83. 3sbio Description and Business Overview

Table 84. 3sbio Interferon Alpha-2a Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 85. 3sbio Interferon Alpha-2a Biosimilar Product

Table 86. 3sbio Recent Development

Table 87. Key Raw Materials Lists

Table 88. Raw Materials Key Suppliers Lists

Table 89. Interferon Alpha-2a Biosimilar Customers List

Table 90. Interferon Alpha-2a Biosimilar Distributors List

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

List of Figures

Figure 1. Interferon Alpha-2a Biosimilar Product Picture

Figure 2. Global Interferon Alpha-2a Biosimilar Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Interferon Alpha-2a Biosimilar Market Size 2018-2029 (US$ Million)

Figure 4. Global Interferon Alpha-2a Biosimilar Sales 2018-2029 (K Units)

Figure 5. India Interferon Alpha-2a Biosimilar Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 6. India Interferon Alpha-2a Biosimilar Market Size 2018-2029 (US$ Million)

Figure 7. India Interferon Alpha-2a Biosimilar Sales 2018-2029 (K Units)

Figure 8. India Interferon Alpha-2a Biosimilar Market Share in Global, in Value (US$ Million) 2018-2029

Figure 9. India Interferon Alpha-2a Biosimilar Market Share in Global, in Volume (K Units) 2018-2029

Figure 10. Interferon Alpha-2a Biosimilar Report Years Considered

Figure 11. Product Picture of Long-lasting Type

Figure 12. Product Picture of Ordinary Type

Figure 13. Global Interferon Alpha-2a Biosimilar Market Share by Type in 2022 & 2029

Figure 14. Global Interferon Alpha-2a Biosimilar Sales in Value by Type (2018-2029) & (US$ Million)

Figure 15. Global Interferon Alpha-2a Biosimilar Sales Market Share in Value by Type (2018-2029)

Figure 16. Global Interferon Alpha-2a Biosimilar Sales by Type (2018-2029) & (K Units)

Figure 17. Global Interferon Alpha-2a Biosimilar Sales Market Share in Volume by Type (2018-2029)

Figure 18. Global Interferon Alpha-2a Biosimilar Price by Type (2018-2029) & (USD/Unit)

Figure 19. India Interferon Alpha-2a Biosimilar Market Share by Type in 2022 & 2029

Figure 20. India Interferon Alpha-2a Biosimilar Sales in Value by Type (2018-2029) & (US$ Million)

Figure 21. India Interferon Alpha-2a Biosimilar Sales Market Share in Value by Type (2018-2029)

Figure 22. India Interferon Alpha-2a Biosimilar Sales by Type (2018-2029) & (K Units)

Figure 23. India Interferon Alpha-2a Biosimilar Sales Market Share in Volume by Type (2018-2029)

Figure 24. India Interferon Alpha-2a Biosimilar Price by Type (2018-2029) & (USD/Unit)

Figure 25. Product Picture of Hepatitis C

Figure 26. Product Picture of Hepatitis B

Figure 27. Product Picture of Others

Figure 28. Global Interferon Alpha-2a Biosimilar Market Share by Application in 2022 & 2029

Figure 29. Global Interferon Alpha-2a Biosimilar Sales in Value by Application (2018-2029) & (US$ Million)

Figure 30. Global Interferon Alpha-2a Biosimilar Sales Market Share in Value by Application (2018-2029)

Figure 31. Global Interferon Alpha-2a Biosimilar Sales by Application (2018-2029) & (K Units)

Figure 32. Global Interferon Alpha-2a Biosimilar Sales Market Share in Volume by Application (2018-2029)

Figure 33. Global Interferon Alpha-2a Biosimilar Price by Application (2018-2029) & (USD/Unit)

Figure 34. India Interferon Alpha-2a Biosimilar Market Share by Application in 2022 & 2029

Figure 35. India Interferon Alpha-2a Biosimilar Sales in Value by Application (2018-2029) & (US$ Million)

Figure 36. India Interferon Alpha-2a Biosimilar Sales Market Share in Value by Application (2018-2029)

Figure 37. India Interferon Alpha-2a Biosimilar Sales by Application (2018-2029) & (K Units)

Figure 38. India Interferon Alpha-2a Biosimilar Sales Market Share in Volume by Application (2018-2029)

Figure 39. India Interferon Alpha-2a Biosimilar Price by Application (2018-2029) & (USD/Unit)

Figure 40. Americas Interferon Alpha-2a Biosimilar Sales in Volume Growth Rate 2018-2029 (K Units)

Figure 41. Americas Interferon Alpha-2a Biosimilar Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 42. Americas Interferon Alpha-2a Biosimilar Sales by Type (2018-2029) & (K Units)

Figure 43. Americas Interferon Alpha-2a Biosimilar Sales Market Share in Volume by Type (2018-2029)

Figure 44. Americas Interferon Alpha-2a Biosimilar Sales by Application (2018-2029) & (K Units)

Figure 45. Americas Interferon Alpha-2a Biosimilar Sales Market Share in Volume by Application (2018-2029)

Figure 46. United States Interferon Alpha-2a Biosimilar Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 47. Canada Interferon Alpha-2a Biosimilar Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 48. Mexico Interferon Alpha-2a Biosimilar Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 49. Brazil Interferon Alpha-2a Biosimilar Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 50. EMEA Interferon Alpha-2a Biosimilar Sales in Volume Growth Rate 2018-2029 (K Units)

Figure 51. EMEA Interferon Alpha-2a Biosimilar Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 52. EMEA Interferon Alpha-2a Biosimilar Sales by Type (2018-2029) & (K Units)

Figure 53. EMEA Interferon Alpha-2a Biosimilar Sales Market Share in Volume by Type (2018-2029)

Figure 54. EMEA Interferon Alpha-2a Biosimilar Sales by Application (2018-2029) & (K Units)

Figure 55. EMEA Interferon Alpha-2a Biosimilar Sales Market Share in Volume by Application (2018-2029)

Figure 56. Europe Interferon Alpha-2a Biosimilar Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 57. Middle East Interferon Alpha-2a Biosimilar Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 58. Africa Interferon Alpha-2a Biosimilar Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 59. China Interferon Alpha-2a Biosimilar Sales in Volume Growth Rate 2018-2029 (K Units)

Figure 60. China Interferon Alpha-2a Biosimilar Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 61. China Interferon Alpha-2a Biosimilar Sales by Type (2018-2029) & (K Units)

Figure 62. China Interferon Alpha-2a Biosimilar Sales Market Share in Volume by Type (2018-2029)

Figure 63. China Interferon Alpha-2a Biosimilar Sales by Application (2018-2029) & (K Units)

Figure 64. China Interferon Alpha-2a Biosimilar Sales Market Share in Volume by Application (2018-2029)

Figure 65. APAC Interferon Alpha-2a Biosimilar Sales in Volume Growth Rate 2018-2029 (K Units)

Figure 66. APAC Interferon Alpha-2a Biosimilar Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 67. APAC Interferon Alpha-2a Biosimilar Sales by Type (2018-2029) & (K Units)

Figure 68. APAC Interferon Alpha-2a Biosimilar Sales Market Share in Volume by Type (2018-2029)

Figure 69. APAC Interferon Alpha-2a Biosimilar Sales by Application (2018-2029) & (K Units)

Figure 70. APAC Interferon Alpha-2a Biosimilar Sales Market Share in Volume by Application (2018-2029)

Figure 71. Japan Interferon Alpha-2a Biosimilar Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 72. South Korea Interferon Alpha-2a Biosimilar Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 73. China Taiwan Interferon Alpha-2a Biosimilar Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 74. Southeast Asia Interferon Alpha-2a Biosimilar Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 75. India Interferon Alpha-2a Biosimilar Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 76. Interferon Alpha-2a Biosimilar Value Chain

Figure 77. Interferon Alpha-2a Biosimilar Production Process

Figure 78. Channels of Distribution

Figure 79. Distributors Profiles

Figure 80. Bottom-up and Top-down Approaches for This Report

Figure 81. Data Triangulation

Figure 82. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions